Format

Send to

Choose Destination
Gastroenterology. 2008 Nov;135(5):1442-7. doi: 10.1053/j.gastro.2008.09.053. Epub 2008 Oct 9.

Current directions in IBD therapy: what goals are feasible with biological modifiers?

Author information

1
Inflammatory Bowel Disease Clinic, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA. william@mayo.edu
PMID:
18848556
DOI:
10.1053/j.gastro.2008.09.053
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center